S., Fussman, C., & Imes, G
Without a long-term strategy, appetite can return and weight regain becomes more likely
Craig Mortensen, DC, IFMCP, QME, IFM-Certified Functional Medicine Physician and founder of Premier IFM in Placentia, CA, serving patients throughout Orange County and Southern California.
A supportive program offering coaching and personalized adjustments can significantly enhance the experience and outcomes for patients
Effective transdermal delivery would require advanced technologies such as: Microneedle arrays : Tiny needles that create microscopic channels in the skin to facilitate drug absorption (these are minimally invasive devices rather than traditional patches) Chemical penetration enhancers : Substances that temporarily increase skin permeability Iontophoresis : Using electrical currents to drive charged molecules through the skin Nanoparticle formulations : Encapsulating drugs in carriers designed to cross skin barriers Several preclinical and early-stage studies have explored these approaches for GLP-1 delivery, with some promising results in laboratory and animal models
Additionally, significant associations of GLP-1 were found with markers of inflammation, including IL-6 and C-reactive protein (CRP) in critically ill patients, and endotoxin, IL-1, and IL-6 were sufficient to induce GLP-1 secretion in mice (61)